Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2272
Peer-review started: October 26, 2022
First decision: December 12, 2022
Revised: January 19, 2023
Accepted: March 31, 2023
Article in press: March 31, 2023
Published online: April 21, 2023
Processing time: 169 Days and 21.8 Hours
Intestinal ultrasound (IUS) is a non-invasive, real-time, cross-sectional imaging tool that can be used at the point-of-care to assess disease activity in patients with Crohn’s disease or ulcerative colitis. IUS promotes quick and impactful treatment decisions that can modify disease progression and enhance patient compliance. This review will summarize the technical aspects of IUS, the evidence to support the use of IUS in disease activity monitoring, the comparison of IUS to current standard of care monitoring modalities such as colonoscopy and calprotectin, and the optimal positioning of IUS in a tight-control monitoring strategy.
Core Tip: Intestinal ultrasound (IUS) is a non-invasive, real-time, cross-sectional imaging tool that is currently underutilized for direct disease activity monitoring in Crohn’s disease (CD) and ulcerative colitis (UC). IUS is the optimal point-of-care method to monitor disease activity in patients with CD or UC with excellent patient compliance and comparison to such traditional monitoring modalities as calprotectin, colonoscopy, and magnetic resonance enterography.
